Rachel McGovern
French drug-maker borrows €220m for MBO - exclusive 2016-02-09 Rachel McGovern French pharmaceutical manufacturing firm Delpharm has borrowed €220 million to back a management buyout that sees the company’s senior staff increase their stake from 85 percent to full ownership, said a source clos
The US leveraged lending market has been leading Europe in terms of attractiveness for the past several months, with the yield gap widening substantially. The two markets are likely to converge again – but will the lending that has increased US yields spread to Europe, or will there be a resurgence of liquidity stateside?
Ken Goldsbrough has joined from Houlihan Lokey to establish a debt advisory practice for Duff & Phelps.
The NYSE-listed alternative investment manager reported a steep year-on-year fall in fourth quarter economic net income and announced a $250m share repurchase programme. The firm’s share price has fallen from around $24 per share a year ago to trade at under $13 per share this week.
Market evolution means investors must reassess what they’re getting into with the second generation of direct lenders.
Andrew Konopelski, partner and head of credit strategies at EQT, and portfolio managers Paul Johnson and Ralph Betz talk about the challenges of launching a direct lending business.
The Munich-based asset manager raised €850m of new capital in 2015 including final commitments to its sixth private debt fund of funds.
As so often in finance, timing is the main question for private lenders seeking to exploit a ripening Spain.
The Iberian lender has gathered almost half its €300m target for its second credit fund.
The fund management arm of the Indian conglomerate plans to raise money for investment in distressed and turnaround situations sourced from the sale of bad loans by Indian banks.